The presented study aims to evaluate of the levels of serum Visfatin, in patients with chronic obstructive Pulmonary diseases in Babylon-Iraq , to find the correlation of Visfatin, with lipid profile in these patients and compared with apparently healthy as case -control study. The study included (50) patients as patients group diagnosed with COPD (G1) and ( 50)as apparently control group(G2) .The age of all studied groups ranged between (40-65)years and BMI with (18.8-24.4) Kg/m 2 .Serum was used in determination of FBS, lipid profile( Ch,TG,HDL-c,LDL-c and VLDL-c) , insulin , CRP and Visfatin , Whole blood was used for determination of HbA1C . The results revealed significant elevation in FBG and HbA1c levels were seen in patients groups when comparing to healthy control .The results indicates a significant elevation in TC, TG ,LDL-c and VLDL-c in G1 comparing to G2. Also , HDL-c significant decreased in G1 comparing to G 2 , Also ,the results showed significant increased in CRP levels in G1 , when comparing to G2, A non significant visfatin and insulin level in G1 when compared with G2(p value = 0.486) , . A non significant correlation was found in G1 between visfatin ,TC,TG, HDL-c and VLDL-c.The conclusion from this study indicate that G1 which HDL-c is low in this group has the highest value for FBS , HbA1c , TC ,TG,LDL and VLDL .Also, the study found non correlation between lipid profile parameters in G1
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.